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ORIGINAL ARTICLE
Third trimester ultrasound soft-tissue measurements accurately
predicts macrosomia
Giuseppe Maria Maruotti, Gabriele Saccone, and Pasquale Martinelli
Department of Neuroscience, Reproductive Sciences and Dentistry, School of Medicine, University of Naples Federico II, Naples, Italy
Abstract
Objective: To evaluate the accuracy of sonographic measurements of fetal soft tissue in the
prediction of macrosomia.
Methods: Electronic databases were searched from their inception until September 2015 with
no limit for language. We included only studies assessing the accuracy of sonographic
measurements of fetal soft tissue in the abdomen or thigh in the prediction of macrosomia
34 weeks of gestation. The primary outcome was the accuracy of sonographic measurements
of fetal soft tissue in the prediction of macrosomia. We generated the forest plot for the pooled
sensitivity and specificity with 95% confidence interval (CI). Additionally, summary receiver-
operating characteristics (ROC) curves were plotted and the area under the curve (AUC) was
also computed to evaluate the overall performance of the diagnostic test accuracy.
Results: Three studies, including 287 singleton gestations, were analyzed. The pooled sensitivity
of sonographic measurements of abdominal or thigh fetal soft tissue in the prediction of
macrosomia was 80% (95% CI: 66–89%) and the pooled specificity was 95% (95% CI: 91–97%).
The AUC for diagnostic accuracy of sonographic measurements of fetal soft tissue in the
prediction of macrosomia was 0.92 and suggested high diagnostic accuracy.
Conclusions: Third-trimester sonographic measurements of fetal soft tissue after 34 weeks may
help to detect macrosomia with a high degree of accuracy. The pooled detection rate was 80%.
A standardization of measurements criteria, reproducibility, building reference charts of fetal
subcutaneous tissue and large studies to assess the optimal cutoff of fetal adipose thickness are
necessary before the introduction of fetal soft-tissue markers in the clinical practice.
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Introduction
Prenatal evaluation of the fetal weight is not always accurate,
especially in fetuses with macrosomia. The term macrosomia
is used to describe an overweight fetus or neonate. Even if
there is no international consensus on the defection of
macrosomia, the most common definition is birth weight
4000 g, which occurs in about 1–10% of all pregnancies [1].
A recent large high-quality population based cohort study
from United States showed that a birth weight 4500 g in
Whites or 4300 in Blacks and Hispanics is the optimal
threshold to define macrosomia and that a birth weight 97th
percentile, irrespective of race, is also reasonable to define
macrosomia [2]. Fetal macrosomia is associated with an
increased risk of perinatal morbidity and mortality. Large
babies have an increased risk of intrapartum complications
such as prolonged labor, shoulder dystocia with brachial
palsy, asphyxia and facial nerve palsy [1]. Women with
diabetes or gestational diabetes mellitus (GDM) are at
increased risk of fetal macrosomia [1,2].
A recent meta-analysis has shown that two-dimensional
(2D) ultrasound estimated fetal weight (EFW), based on a
combination of sonographic fetal measurements, was an
overall poor predictor of fetal macrosomia and that magnetic
resonance imaging (MRI) volumetry to estimate fetal weight
appeared to be much more sensitive than 2D ultrasound EFW
for predicting fetal macrosomia [3]. Evaluation of fetal soft
tissue has been recently proposed to improve birth weight
prediction by ultrasound and it has been shown that the
precision of EFW may be improved by adding fractional limb
volume measurements to conventional 2D ultrasound
biometry.
The aim of this systematic review and meta-analysis was to
evaluate the accuracy of sonographic measurements of fetal
soft tissue in the prediction of macrosomia.
Methods
This review was performed according to a protocol designed a
priori and recommended for systematic review [4]. Electronic
databases (MEDLINE, PROSPERO, Scopus, ClinicalTrials.gov,
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EMBASE, Sciencedirect, the Cochrane Library; Scielo) were
searched from their inception until September 2015 with no limit
for language. Search terms used were the following text words:
‘‘macrosomia,’’ ‘‘ultrasound,’’ ‘‘fetal weight,’’ ‘‘EFW,’’ ‘‘dia-
betes,’’ ‘‘large for gestational age,’’ ‘‘shoulder dystocia;’’
‘‘pregnancy;’’ ‘‘MRI;’’ ‘‘2D;’’ ‘‘3D;’’ ‘‘accuracy;’’ ‘‘system-
atic review; ‘‘meta-analysis,’’ ‘‘metaanalysis,’’ ‘‘prediction,’’
‘‘birthweight,’’ ‘‘biometry,’’ ‘‘limb,’’ ‘‘obstetric,’’ ‘‘volume’’
and ‘‘soft tissue.’’ No restrictions for language or geographic
location were applied. In addition, the reference lists of all
identified articles were examined to identify studies not captured
by electronic searches. The electronic search and the eligibility
of the studies were independently assessed by two authors
(GMM, GS). Differences were discussed and consensus reached.
We considered randomized controlled trials, case–control
and cohort studies. Studies were included if they reported data
allowing construction of a 2 2 table. We included only
studies assessing the accuracy of sonographic measurements
of fetal soft tissue in the prediction of macrosomia at 34
weeks of gestation. Only studies that measured fetal soft
tissue in the abdomen or thigh were included. The primary
outcome was the accuracy of sonographic measurements of
fetal soft tissue in prediction of macrosomia, as defined in the
original studies.
Data abstraction and methodological quality of the
included studies were completed by two independent inves-
tigators (GMM, GS). Each investigator independently
abstracted data from each study separately. Data from each
eligible study were extracted without modification of original
data onto custom-made data collection forms. Disagreements
were resolved by consensus with a third reviewer (PM). All
authors of the original studies were contacted for missing data
if possible.
The quality assessment of each included study was
assessed by using Quality Assessment of Diagnostic
Accuracy Studies (QUADAS) criteria [5]. The meta-analysis
was reported following the Preferred Reporting Item for
Systematic Reviews and Meta-analyzes (PRISMA) statement
[6]. Before data extraction, the review was registered with the
PROSPERO International Prospective Register of Systematic
Reviews (registration No.: CRD42015026372) following the
PRIMA guidelines for protocols (PRIMSA-P) [7].
For all the included studies, we constructed a 2 2 table
cross-classifying ultrasound measurement of fetal soft tissue
and the prediction of macrosomia. We generated the forest
plot for the pooled sensitivity (i.e. detection rate) and
specificity with 95% confidence interval (CI). The forest
plot, also known as a bloobbogram, is a graphical display of
estimated results and pooled data from the studies included in
the meta-analysis [4].
Additionally, symmetric summary receiver-operating char-
acteristics (sROC) curves were plotted. sROC analysis is a
recently developed statistical technique that can be applied to
meta-analysis of diagnostic tests [8]. The area under the curve
(AUC) and the Q* index were also computed to evaluate the
overall performance of the diagnostic test accuracy. The AUC
of an sROC curve is a measure of the overall performance of a
diagnostic test in accurately differentiating those cases with
and those without the condition of interest. The Q* index is
defined by the point at which sensitivity and specificity are
equal, which is closest to the ideal top-left corner of the sROC
space. Both values range between 0 and 1, with higher values
indicating better test performance [8]. The following guide-
lines have been suggested for the interpretation of AUC
values: low (0.5AUC50.7), moderate (0.7AUC50.9) or
high (0.9AUC1) accuracy [8]. We planned to assess the
AUC in subgroup analysis according to the fetal soft tissue
used. We also planned to assess an indirect meta-analysis to
compared to AUC between the different fetal soft tissue used
by the original studies.
Given that the individual estimates of treatment effect
would vary by chance and some variation is expected; the
degrees of between-study heterogeneity were evaluated by
using the I2 statistic, which represents the percentage of
between-study variation that is due to heterogeneity rather
than chance. A value of 30% indicate a substantial level of
heterogeneity [4,9].
Potential publication biases were assessed statistically by
using Begg’s and Egger’s tests and by using the Deeks’
asymmetry test for publication bias [4,9].
The data analysis was completed independently by authors
(GMM, GS) using Meta-DiSc 1.4 (Zamora). The completed
analyses were then compared, and any difference was resolved
with review of the entire data.
Results
The flow of study identification is shown in Figure 1. Three
prospective cohort studies, including 287 women, were
Figure 1. Flow diagram of studies identified in the systematic review.
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analyzed [10–12]. Publication bias, assessed using Begg’s and
Egger’s tests, showed no significant bias (p ¼ 0.62 and
p ¼ 0.71, respectively). Deeks’ test showed no significant
asymmetry (p ¼ 0.88). The statistical heterogeneity between
the included studies was low (I2¼0%). Figure 2 shows the
results of the quality assessment presented as percentages
across the studies. None of them had high risk of bias in
patient selection and index test. Table 1 shows the character-
istics of the included studies. All of them were prospective
cohort studies, included only singleton gestations, and
excluded multiple pregnancies. Two studies came from
Europe [10,11], and one from United States [12]. While
Petrikovsky et al. included all women with singleton gesta-
tions [12]; the other two studies included only singletons with
an increased risk of macrosomia [10,11]: Pagani et al
included only women with GDM [11], and Grabedian et al.
included only women with pregestational diabetes [10]. The
method of ultrasound ascertainment was clearly described in
all the individual studies. In one study, all examinations were
performed with an Acuson XP128/10 using a 3.5 MHz and
5 MHz curvilinear probe, the fetal abdominal subcutaneous
tissue thickness was measured in the anterior third of the
abdominal circumference by placing the cursor at the outer
and inner edges of the echogenic subcutaneous fat line [12].
Grabedian et al used a 5 MHz curvilinear probe to measure
the abdominal subcutaneous tissue thickness [10]. In the
Italian study, all ultrasound examinations were performed by
using a conventional transabdominal two-dimensional (2D)
scan in order to obtain the EFW, while 3D volumes were
acquired from the thigh to obtain fractional thigh volume
(TVol) [11].
From all the included studies, we were able to construct a
2 2 table for the prediction of macrosomia by using
sonographic measurements of fetal soft tissue. Pooled results
from the meta-analysis showed that sensitivity of sonographic
measurements of fetal soft tissue in the prediction of
macrosomia ranged from 70% to 87% and specificity from
79% to 96%. The pooled sensitivity (i.e. detection rate) was
80% (95% CI: 66–89%) and the pooled specificity was 95%
(95% CI: 91–97%). The pooled positive predictive value and
the pooled negative predictive value were 78% (95% CI: 67–
85%) and 95% (95% CI: 89–92%), respectively. The AUC for
diagnostic accuracy of sonographic measurements of fetal soft
tissue in the prediction of macrosomia was 0.92 and suggested
high diagnostic accuracy (Figure 3). The AUC was high in
both subgroup analysis of only studies on abdominal fetal soft
tissue (AUC¼ 0.90) and of only studies on thigh fetal soft
tissue (AUC¼ 0.93). The indirect meta-analysis showed that
the TVol had a significantly higher detection rate compared to
abdominal fetal soft tissue (p 50.0001).
Discussion
This systematic review and meta-analysis, assessing the
accuracy of sonographic measurements of fetal soft tissue in
the prediction of macrosomia, showed that third-trimester
sonographic measurements of fetal soft tissue may help to
detect macrosomia. Particularly, our findings showed that
fetal soft tissue has high diagnostic accuracy in the prediction
of macrosomia. The pooled detection rate was 80%.
Our study has several strengths. This may be the first meta-
analysis evaluating the accuracy of sonographic measure-
ments of fetal soft tissue in the prediction of macrosomia. No
similar meta-analyses were found during the systematic
review. The overall risk of bias of the included studies
was low. All the included studies had the same primary
outcome, that is, the prediction of macrosomia. The protocol
of this review was a priori registered on PROSPERO.
Table 1. Characteristics of the included studies.
Petrikovsky 1997[12] Grabedian 2013[10] Pagani 2014[11]
Location USA France Italy
Study Design Prospective cohort Prospective cohort Prospective cohort
Inclusion criteria Singletons Singletons with diabetes mellitus Singletons with GDM
Sample size 133 29 125
Soft-tissue thickness Abdominal subcutaneous tissue
thickness 11 mm
Abdominal subcutaneous tissue
thickness 11 mm
TVol
GA at measurements (weeks) 37–42 34 34–36
Other sonographic measurements Not reported Fetal biometry, liver size, STT, STA, STS Fetal biometry
Primary outcome Prediction of macrosomia Prediction of macrosomia Prediction of macrosomia
Definition of macrosomia Birthweight44000 g Birth weight490th percentile Birthweight44000 g
GA, gestational age; GDM, gestational diabetes mellitus; TVol, fractional thigh volume.
Figure 2. Review authors’ judgment of risk of bias and applicability concerns based on Quality Assessment of Diagnostic Accuracy Studies tool
presented as percentages across included studies.
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Statistical tests showed no significant potential publication
biases. The statistical heterogeneity between the included
studies was low with no inconsistency in the pooled results
(I2¼0%).
Limitations of our study are mostly inherent to the
limitations of the included studies. All the included studies
were cohort studies and had different inclusion criteria. The
soft-tissue markers used were different: Pagani et al. reported
the accuracy of TVol-based methods for the prediction of
macrosomia in gestational diabetic pregnancies, while the
other two studies used abdominal subcutaneous tissue thick-
ness (Table 1). The number of the included women and the
number of the included studies were limited and for this
reason assessing subgroup and sensitivity analysis according
to inclusion criteria and according to the soft tissue used were
not feasible. The predictive values of a given markers may
significantly vary across the gestational age range from 34 to
42 weeks. Unfortunately, since none of the included studies
stratified for and reported data by gestational age, a subgroup
analysis according to gestational age was not feasible. The
predictive values are dependent on the prior probability of an
event happening, and therefore, they cannot be generalized for
the whole pregnancy interval covered by this meta-analysis.
The generalizability and the external validity of these findings
may be limited due to the quality of ultrasound employed at
these institutions and the patient population evaluated. No
adjustment for potential confounders were made by the
original studies. The sample size was small and this is a major
shortcoming of the meta-analysis. The three selected studies
have in common that they analyzed fetal soft tissue in the
prediction of macrosomia in singleton pregnancies, but they
are not comparable in other terms, such as geographical areas
with significant nutritional and anthropometric differences,
inclusion or exclusion of diabetes and different fetal soft
tissues under study.
Management of macrosomia provides a challenge in
modern obstetrics. Studies about macrosomia are limited by
their retrospective design, by the nonuniform definition of
macrosomia, and because they are not randomized. So far, the
role of the ultrasound in the definition, diagnosis and
management of macrosomia is debate. Various methods
based on regression analysis, decision trees and clinical risk
score have been proposed [13–15]. The current tools available
to predict fetal macrosomia perform poorly [3].
Ultrasonography examinations are commonly used to estimate
fetal weight and to predict macrosomia. A recent meta-
analysis has shown that 2D ultrasound fetal biometry was an
overall poor predictor of fetal macrosomia [3].
Complementary methods for the prenatal assessment of
generalized nutritional status may also be possible beyond
the use of EFW as well. In 2009, Lee et al. provided normal
reference ranges for fetal soft tissue as a new index of
generalized fetal nutritional status and reported technical
considerations for this technique [16]. They showed that fetal
soft tissue, such as fractional limb volume assessment, may
improve the detection and monitoring of malnourished fetuses
[16]; and so sonographic measurements of fetal soft tissue has
been recently proposed in the prediction of macrosomia [10–
12,16]. Being able to predict macrosomia has several
potential benefits because failure to detect it may be
associated with higher rates of neonatal morbidity and
mortality [1,2,17]. Providers and birth locals may be able to
better plan staff and coverage [17].
In summary, third-trimester sonographic measurements of
fetal soft tissue after 34 weeks may help to detect macrosomia
with a high degree of accuracy and an 80% of detection rate.
Figure 3. Symmetric summary receiver operating characteristics curve with 95% confidence interval for the accuracy of sonographic measurements of
fetal soft tissue in prediction of macrosomia. Area under the curve (AUC) ± standard error (SE)¼ 0.925 ± 0.05; Q* ± SE¼ 0.859 ± 0.05.
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Fetal soft tissue as a screening test for the prediction of
macrosomia may be best considered in women who might
most benefit from this test. A standardization of measure-
ments criteria, reproducibility, building reference charts of
fetal subcutaneous tissue and large studies to assess the
optimal cutoff of fetal adipose thickness are necessary before
the introduction of fetal soft-tissue markers in the clinical
practice.
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